These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...
Q2 2025 Earnings Conference Call October 31, 2024 2:30 AM ET. Company Participants. Hiroyuki Okuzawa - Representative Director, Presi ...
(IN BRIEF) AstraZeneca presented significant advancements ... diff) infections, which can cause severe intestinal issues. In addition, vaccine effectiveness data on FluMist, the only self-administered ...
In September, AstraZeneca's subsidiary MedImmune gained approval for a live H1N1 Flumist vaccine. Further afield, Beijing-based Sinovac Biotech also received approval for an H1N1 vaccine from the ...
If you’re on the fence about investing in Merck & Co., Inc. or AstraZeneca PLC because you’re not sure ... and Januvia brands, as well as vaccine products consisting of preventive pediatric, ...
But next year, you could get vaccinated for the flu at home. Just last month, the FDA approved FluMist, a nasal-spray flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback